Menu

Recent Advances in Immunotherapy: Directing Cells to Address Disease

The Scientist is bringing together a panel of experts to review the past, present, and future of immunotherapy, and share the details of their research into new treatments. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Mar 29, 2017
The Scientist Creative Services Team

Recent Advances in Immunotherapy: Directing Cells to Address Disease from thescientistllc on Vimeo.

To target diseases such as cancer and HIV, scientists are now successfully programming the immune system to seek out and destroy the agents of disease, even when those agents are the body’s own cells. Immunotherapy has demonstrated remarkable efficacy in treatment of previously undruggable diseases, leading to calls for standardization and additional research. The Scientist is bringing together a panel of experts to review the current knowledge base, share their recent work, and discuss the future of immunotherapy. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Topics to be covered:

  • Progress in immunotherapies, from cancer to HIV
  • Immunotherapy research and development

View the Video Now

Meet the Speakers:

Leena Gandhi, MD, PhD
Director, Thoracic Medical Oncology,
 NYU Langone Medical Center
Associate Professor, Department of Medicine,
 NYU Perlmutter Cancer Center

 

 


 

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.